Global Dexlansoprazole Sustained Release Capsule Market Growth 2026-2032
The global Dexlansoprazole Sustained Release Capsule market size is predicted to grow from US$ 337 million in 2025 to US$ 487 million in 2032; it is expected to grow at a CAGR of 5.5% from 2026 to 2032.
Dexlansoprazole sustained-release capsules were approved by the U.S. FDA in January 2009, under the trade name DEXILANT. For the treatment of heartburn caused by non-erosive gastroesophageal reflux disease (GERD), erosive esophagitis (EE) and maintenance treatment after healing of erosive esophagitis, all of which are administered once a day.
United States market for Dexlansoprazole Sustained Release Capsule is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Dexlansoprazole Sustained Release Capsule is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Dexlansoprazole Sustained Release Capsule is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Dexlansoprazole Sustained Release Capsule players cover TAKEDA PHARM, PAR PHARM, TWI PHARM, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Dexlansoprazole Sustained Release Capsule Industry Forecast? looks at past sales and reviews total world Dexlansoprazole Sustained Release Capsule sales in 2025, providing a comprehensive analysis by region and market sector of projected Dexlansoprazole Sustained Release Capsule sales for 2026 through 2032. With Dexlansoprazole Sustained Release Capsule sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dexlansoprazole Sustained Release Capsule industry.
This Insight Report provides a comprehensive analysis of the global Dexlansoprazole Sustained Release Capsule landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dexlansoprazole Sustained Release Capsule portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Dexlansoprazole Sustained Release Capsule market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dexlansoprazole Sustained Release Capsule and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dexlansoprazole Sustained Release Capsule.
This report presents a comprehensive overview, market shares, and growth opportunities of Dexlansoprazole Sustained Release Capsule market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Dexlansoprazole sustained-release capsules were approved by the U.S. FDA in January 2009, under the trade name DEXILANT. For the treatment of heartburn caused by non-erosive gastroesophageal reflux disease (GERD), erosive esophagitis (EE) and maintenance treatment after healing of erosive esophagitis, all of which are administered once a day.
United States market for Dexlansoprazole Sustained Release Capsule is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Dexlansoprazole Sustained Release Capsule is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Dexlansoprazole Sustained Release Capsule is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Dexlansoprazole Sustained Release Capsule players cover TAKEDA PHARM, PAR PHARM, TWI PHARM, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Dexlansoprazole Sustained Release Capsule Industry Forecast? looks at past sales and reviews total world Dexlansoprazole Sustained Release Capsule sales in 2025, providing a comprehensive analysis by region and market sector of projected Dexlansoprazole Sustained Release Capsule sales for 2026 through 2032. With Dexlansoprazole Sustained Release Capsule sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dexlansoprazole Sustained Release Capsule industry.
This Insight Report provides a comprehensive analysis of the global Dexlansoprazole Sustained Release Capsule landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dexlansoprazole Sustained Release Capsule portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Dexlansoprazole Sustained Release Capsule market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dexlansoprazole Sustained Release Capsule and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dexlansoprazole Sustained Release Capsule.
This report presents a comprehensive overview, market shares, and growth opportunities of Dexlansoprazole Sustained Release Capsule market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 30MG
- 60MG
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- TAKEDA PHARM
- PAR PHARM
- TWI PHARM
- What is the 10-year outlook for the global Dexlansoprazole Sustained Release Capsule market?
- What factors are driving Dexlansoprazole Sustained Release Capsule market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Dexlansoprazole Sustained Release Capsule market opportunities vary by end market size?
- How does Dexlansoprazole Sustained Release Capsule break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Dexlansoprazole Sustained Release Capsule Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Dexlansoprazole Sustained Release Capsule by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Dexlansoprazole Sustained Release Capsule by Country/Region, 2021, 2025 & 2032
2.2 Dexlansoprazole Sustained Release Capsule Segment by Type
2.2.1 30MG
2.2.2 60MG
2.2.3 Dexlansoprazole Sustained Release Capsule Sales by Type
2.2.3.1 Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Type (2021-2026)
2.2.3.2 Global Dexlansoprazole Sustained Release Capsule Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Dexlansoprazole Sustained Release Capsule Sale Price by Type (2021-2026)
2.3 Dexlansoprazole Sustained Release Capsule Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Dexlansoprazole Sustained Release Capsule Sales by Application
2.3.3.1 Global Dexlansoprazole Sustained Release Capsule Sale Market Share by Application (2021-2026)
2.3.3.2 Global Dexlansoprazole Sustained Release Capsule Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Dexlansoprazole Sustained Release Capsule Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Dexlansoprazole Sustained Release Capsule Breakdown Data by Company
3.1.1 Global Dexlansoprazole Sustained Release Capsule Annual Sales by Company (2021-2026)
3.1.2 Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Company (2021-2026)
3.2 Global Dexlansoprazole Sustained Release Capsule Annual Revenue by Company (2021-2026)
3.2.1 Global Dexlansoprazole Sustained Release Capsule Revenue by Company (2021-2026)
3.2.2 Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Company (2021-2026)
3.3 Global Dexlansoprazole Sustained Release Capsule Sale Price by Company
3.4 Key Manufacturers Dexlansoprazole Sustained Release Capsule Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dexlansoprazole Sustained Release Capsule Product Location Distribution
3.4.2 Players Dexlansoprazole Sustained Release Capsule Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DEXLANSOPRAZOLE SUSTAINED RELEASE CAPSULE BY GEOGRAPHIC REGION
4.1 World Historic Dexlansoprazole Sustained Release Capsule Market Size by Geographic Region (2021-2026)
4.1.1 Global Dexlansoprazole Sustained Release Capsule Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Dexlansoprazole Sustained Release Capsule Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Dexlansoprazole Sustained Release Capsule Market Size by Country/Region (2021-2026)
4.2.1 Global Dexlansoprazole Sustained Release Capsule Annual Sales by Country/Region (2021-2026)
4.2.2 Global Dexlansoprazole Sustained Release Capsule Annual Revenue by Country/Region (2021-2026)
4.3 Americas Dexlansoprazole Sustained Release Capsule Sales Growth
4.4 APAC Dexlansoprazole Sustained Release Capsule Sales Growth
4.5 Europe Dexlansoprazole Sustained Release Capsule Sales Growth
4.6 Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Growth
5 AMERICAS
5.1 Americas Dexlansoprazole Sustained Release Capsule Sales by Country
5.1.1 Americas Dexlansoprazole Sustained Release Capsule Sales by Country (2021-2026)
5.1.2 Americas Dexlansoprazole Sustained Release Capsule Revenue by Country (2021-2026)
5.2 Americas Dexlansoprazole Sustained Release Capsule Sales by Type (2021-2026)
5.3 Americas Dexlansoprazole Sustained Release Capsule Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dexlansoprazole Sustained Release Capsule Sales by Region
6.1.1 APAC Dexlansoprazole Sustained Release Capsule Sales by Region (2021-2026)
6.1.2 APAC Dexlansoprazole Sustained Release Capsule Revenue by Region (2021-2026)
6.2 APAC Dexlansoprazole Sustained Release Capsule Sales by Type (2021-2026)
6.3 APAC Dexlansoprazole Sustained Release Capsule Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Dexlansoprazole Sustained Release Capsule by Country
7.1.1 Europe Dexlansoprazole Sustained Release Capsule Sales by Country (2021-2026)
7.1.2 Europe Dexlansoprazole Sustained Release Capsule Revenue by Country (2021-2026)
7.2 Europe Dexlansoprazole Sustained Release Capsule Sales by Type (2021-2026)
7.3 Europe Dexlansoprazole Sustained Release Capsule Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Dexlansoprazole Sustained Release Capsule by Country
8.1.1 Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales by Country (2021-2026)
8.1.2 Middle East & Africa Dexlansoprazole Sustained Release Capsule Revenue by Country (2021-2026)
8.2 Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales by Type (2021-2026)
8.3 Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dexlansoprazole Sustained Release Capsule
10.3 Manufacturing Process Analysis of Dexlansoprazole Sustained Release Capsule
10.4 Industry Chain Structure of Dexlansoprazole Sustained Release Capsule
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dexlansoprazole Sustained Release Capsule Distributors
11.3 Dexlansoprazole Sustained Release Capsule Customer
12 WORLD FORECAST REVIEW FOR DEXLANSOPRAZOLE SUSTAINED RELEASE CAPSULE BY GEOGRAPHIC REGION
12.1 Global Dexlansoprazole Sustained Release Capsule Market Size Forecast by Region
12.1.1 Global Dexlansoprazole Sustained Release Capsule Forecast by Region (2027-2032)
12.1.2 Global Dexlansoprazole Sustained Release Capsule Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Dexlansoprazole Sustained Release Capsule Forecast by Type (2027-2032)
12.7 Global Dexlansoprazole Sustained Release Capsule Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 TAKEDA PHARM
13.1.1 TAKEDA PHARM Company Information
13.1.2 TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Product Portfolios and Specifications
13.1.3 TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 TAKEDA PHARM Main Business Overview
13.1.5 TAKEDA PHARM Latest Developments
13.2 PAR PHARM
13.2.1 PAR PHARM Company Information
13.2.2 PAR PHARM Dexlansoprazole Sustained Release Capsule Product Portfolios and Specifications
13.2.3 PAR PHARM Dexlansoprazole Sustained Release Capsule Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 PAR PHARM Main Business Overview
13.2.5 PAR PHARM Latest Developments
13.3 TWI PHARM
13.3.1 TWI PHARM Company Information
13.3.2 TWI PHARM Dexlansoprazole Sustained Release Capsule Product Portfolios and Specifications
13.3.3 TWI PHARM Dexlansoprazole Sustained Release Capsule Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 TWI PHARM Main Business Overview
13.3.5 TWI PHARM Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Dexlansoprazole Sustained Release Capsule Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Dexlansoprazole Sustained Release Capsule by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Dexlansoprazole Sustained Release Capsule by Country/Region, 2021, 2025 & 2032
2.2 Dexlansoprazole Sustained Release Capsule Segment by Type
2.2.1 30MG
2.2.2 60MG
2.2.3 Dexlansoprazole Sustained Release Capsule Sales by Type
2.2.3.1 Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Type (2021-2026)
2.2.3.2 Global Dexlansoprazole Sustained Release Capsule Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Dexlansoprazole Sustained Release Capsule Sale Price by Type (2021-2026)
2.3 Dexlansoprazole Sustained Release Capsule Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Dexlansoprazole Sustained Release Capsule Sales by Application
2.3.3.1 Global Dexlansoprazole Sustained Release Capsule Sale Market Share by Application (2021-2026)
2.3.3.2 Global Dexlansoprazole Sustained Release Capsule Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Dexlansoprazole Sustained Release Capsule Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Dexlansoprazole Sustained Release Capsule Breakdown Data by Company
3.1.1 Global Dexlansoprazole Sustained Release Capsule Annual Sales by Company (2021-2026)
3.1.2 Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Company (2021-2026)
3.2 Global Dexlansoprazole Sustained Release Capsule Annual Revenue by Company (2021-2026)
3.2.1 Global Dexlansoprazole Sustained Release Capsule Revenue by Company (2021-2026)
3.2.2 Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Company (2021-2026)
3.3 Global Dexlansoprazole Sustained Release Capsule Sale Price by Company
3.4 Key Manufacturers Dexlansoprazole Sustained Release Capsule Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dexlansoprazole Sustained Release Capsule Product Location Distribution
3.4.2 Players Dexlansoprazole Sustained Release Capsule Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DEXLANSOPRAZOLE SUSTAINED RELEASE CAPSULE BY GEOGRAPHIC REGION
4.1 World Historic Dexlansoprazole Sustained Release Capsule Market Size by Geographic Region (2021-2026)
4.1.1 Global Dexlansoprazole Sustained Release Capsule Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Dexlansoprazole Sustained Release Capsule Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Dexlansoprazole Sustained Release Capsule Market Size by Country/Region (2021-2026)
4.2.1 Global Dexlansoprazole Sustained Release Capsule Annual Sales by Country/Region (2021-2026)
4.2.2 Global Dexlansoprazole Sustained Release Capsule Annual Revenue by Country/Region (2021-2026)
4.3 Americas Dexlansoprazole Sustained Release Capsule Sales Growth
4.4 APAC Dexlansoprazole Sustained Release Capsule Sales Growth
4.5 Europe Dexlansoprazole Sustained Release Capsule Sales Growth
4.6 Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Growth
5 AMERICAS
5.1 Americas Dexlansoprazole Sustained Release Capsule Sales by Country
5.1.1 Americas Dexlansoprazole Sustained Release Capsule Sales by Country (2021-2026)
5.1.2 Americas Dexlansoprazole Sustained Release Capsule Revenue by Country (2021-2026)
5.2 Americas Dexlansoprazole Sustained Release Capsule Sales by Type (2021-2026)
5.3 Americas Dexlansoprazole Sustained Release Capsule Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dexlansoprazole Sustained Release Capsule Sales by Region
6.1.1 APAC Dexlansoprazole Sustained Release Capsule Sales by Region (2021-2026)
6.1.2 APAC Dexlansoprazole Sustained Release Capsule Revenue by Region (2021-2026)
6.2 APAC Dexlansoprazole Sustained Release Capsule Sales by Type (2021-2026)
6.3 APAC Dexlansoprazole Sustained Release Capsule Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Dexlansoprazole Sustained Release Capsule by Country
7.1.1 Europe Dexlansoprazole Sustained Release Capsule Sales by Country (2021-2026)
7.1.2 Europe Dexlansoprazole Sustained Release Capsule Revenue by Country (2021-2026)
7.2 Europe Dexlansoprazole Sustained Release Capsule Sales by Type (2021-2026)
7.3 Europe Dexlansoprazole Sustained Release Capsule Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Dexlansoprazole Sustained Release Capsule by Country
8.1.1 Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales by Country (2021-2026)
8.1.2 Middle East & Africa Dexlansoprazole Sustained Release Capsule Revenue by Country (2021-2026)
8.2 Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales by Type (2021-2026)
8.3 Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dexlansoprazole Sustained Release Capsule
10.3 Manufacturing Process Analysis of Dexlansoprazole Sustained Release Capsule
10.4 Industry Chain Structure of Dexlansoprazole Sustained Release Capsule
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dexlansoprazole Sustained Release Capsule Distributors
11.3 Dexlansoprazole Sustained Release Capsule Customer
12 WORLD FORECAST REVIEW FOR DEXLANSOPRAZOLE SUSTAINED RELEASE CAPSULE BY GEOGRAPHIC REGION
12.1 Global Dexlansoprazole Sustained Release Capsule Market Size Forecast by Region
12.1.1 Global Dexlansoprazole Sustained Release Capsule Forecast by Region (2027-2032)
12.1.2 Global Dexlansoprazole Sustained Release Capsule Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Dexlansoprazole Sustained Release Capsule Forecast by Type (2027-2032)
12.7 Global Dexlansoprazole Sustained Release Capsule Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 TAKEDA PHARM
13.1.1 TAKEDA PHARM Company Information
13.1.2 TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Product Portfolios and Specifications
13.1.3 TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 TAKEDA PHARM Main Business Overview
13.1.5 TAKEDA PHARM Latest Developments
13.2 PAR PHARM
13.2.1 PAR PHARM Company Information
13.2.2 PAR PHARM Dexlansoprazole Sustained Release Capsule Product Portfolios and Specifications
13.2.3 PAR PHARM Dexlansoprazole Sustained Release Capsule Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 PAR PHARM Main Business Overview
13.2.5 PAR PHARM Latest Developments
13.3 TWI PHARM
13.3.1 TWI PHARM Company Information
13.3.2 TWI PHARM Dexlansoprazole Sustained Release Capsule Product Portfolios and Specifications
13.3.3 TWI PHARM Dexlansoprazole Sustained Release Capsule Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 TWI PHARM Main Business Overview
13.3.5 TWI PHARM Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Dexlansoprazole Sustained Release Capsule Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Dexlansoprazole Sustained Release Capsule Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 30MG
Table 4. Major Players of 60MG
Table 5. Global Dexlansoprazole Sustained Release Capsule Sales by Type (2021-2026) & (K Units)
Table 6. Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Type (2021-2026)
Table 7. Global Dexlansoprazole Sustained Release Capsule Revenue by Type (2021-2026) & ($ million)
Table 8. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Type (2021-2026)
Table 9. Global Dexlansoprazole Sustained Release Capsule Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Dexlansoprazole Sustained Release Capsule Sale by Application (2021-2026) & (K Units)
Table 11. Global Dexlansoprazole Sustained Release Capsule Sale Market Share by Application (2021-2026)
Table 12. Global Dexlansoprazole Sustained Release Capsule Revenue by Application (2021-2026) & ($ million)
Table 13. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Application (2021-2026)
Table 14. Global Dexlansoprazole Sustained Release Capsule Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Dexlansoprazole Sustained Release Capsule Sales by Company (2021-2026) & (K Units)
Table 16. Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Company (2021-2026)
Table 17. Global Dexlansoprazole Sustained Release Capsule Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Company (2021-2026)
Table 19. Global Dexlansoprazole Sustained Release Capsule Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Dexlansoprazole Sustained Release Capsule Producing Area Distribution and Sales Area
Table 21. Players Dexlansoprazole Sustained Release Capsule Products Offered
Table 22. Dexlansoprazole Sustained Release Capsule Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Dexlansoprazole Sustained Release Capsule Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Dexlansoprazole Sustained Release Capsule Sales Market Share Geographic Region (2021-2026)
Table 27. Global Dexlansoprazole Sustained Release Capsule Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Dexlansoprazole Sustained Release Capsule Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Country/Region (2021-2026)
Table 31. Global Dexlansoprazole Sustained Release Capsule Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Dexlansoprazole Sustained Release Capsule Sales by Country (2021-2026) & (K Units)
Table 34. Americas Dexlansoprazole Sustained Release Capsule Sales Market Share by Country (2021-2026)
Table 35. Americas Dexlansoprazole Sustained Release Capsule Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Dexlansoprazole Sustained Release Capsule Sales by Type (2021-2026) & (K Units)
Table 37. Americas Dexlansoprazole Sustained Release Capsule Sales by Application (2021-2026) & (K Units)
Table 38. APAC Dexlansoprazole Sustained Release Capsule Sales by Region (2021-2026) & (K Units)
Table 39. APAC Dexlansoprazole Sustained Release Capsule Sales Market Share by Region (2021-2026)
Table 40. APAC Dexlansoprazole Sustained Release Capsule Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Dexlansoprazole Sustained Release Capsule Sales by Type (2021-2026) & (K Units)
Table 42. APAC Dexlansoprazole Sustained Release Capsule Sales by Application (2021-2026) & (K Units)
Table 43. Europe Dexlansoprazole Sustained Release Capsule Sales by Country (2021-2026) & (K Units)
Table 44. Europe Dexlansoprazole Sustained Release Capsule Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Dexlansoprazole Sustained Release Capsule Sales by Type (2021-2026) & (K Units)
Table 46. Europe Dexlansoprazole Sustained Release Capsule Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Dexlansoprazole Sustained Release Capsule Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Dexlansoprazole Sustained Release Capsule
Table 52. Key Market Challenges & Risks of Dexlansoprazole Sustained Release Capsule
Table 53. Key Industry Trends of Dexlansoprazole Sustained Release Capsule
Table 54. Dexlansoprazole Sustained Release Capsule Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Dexlansoprazole Sustained Release Capsule Distributors List
Table 57. Dexlansoprazole Sustained Release Capsule Customer List
Table 58. Global Dexlansoprazole Sustained Release Capsule Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Dexlansoprazole Sustained Release Capsule Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Dexlansoprazole Sustained Release Capsule Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Dexlansoprazole Sustained Release Capsule Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Dexlansoprazole Sustained Release Capsule Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Dexlansoprazole Sustained Release Capsule Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Dexlansoprazole Sustained Release Capsule Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Dexlansoprazole Sustained Release Capsule Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Dexlansoprazole Sustained Release Capsule Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Dexlansoprazole Sustained Release Capsule Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Dexlansoprazole Sustained Release Capsule Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Dexlansoprazole Sustained Release Capsule Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Dexlansoprazole Sustained Release Capsule Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. TAKEDA PHARM Basic Information, Dexlansoprazole Sustained Release Capsule Manufacturing Base, Sales Area and Its Competitors
Table 73. TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Product Portfolios and Specifications
Table 74. TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. TAKEDA PHARM Main Business
Table 76. TAKEDA PHARM Latest Developments
Table 77. PAR PHARM Basic Information, Dexlansoprazole Sustained Release Capsule Manufacturing Base, Sales Area and Its Competitors
Table 78. PAR PHARM Dexlansoprazole Sustained Release Capsule Product Portfolios and Specifications
Table 79. PAR PHARM Dexlansoprazole Sustained Release Capsule Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. PAR PHARM Main Business
Table 81. PAR PHARM Latest Developments
Table 82. TWI PHARM Basic Information, Dexlansoprazole Sustained Release Capsule Manufacturing Base, Sales Area and Its Competitors
Table 83. TWI PHARM Dexlansoprazole Sustained Release Capsule Product Portfolios and Specifications
Table 84. TWI PHARM Dexlansoprazole Sustained Release Capsule Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. TWI PHARM Main Business
Table 86. TWI PHARM Latest Developments
Table 1. Dexlansoprazole Sustained Release Capsule Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Dexlansoprazole Sustained Release Capsule Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 30MG
Table 4. Major Players of 60MG
Table 5. Global Dexlansoprazole Sustained Release Capsule Sales by Type (2021-2026) & (K Units)
Table 6. Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Type (2021-2026)
Table 7. Global Dexlansoprazole Sustained Release Capsule Revenue by Type (2021-2026) & ($ million)
Table 8. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Type (2021-2026)
Table 9. Global Dexlansoprazole Sustained Release Capsule Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Dexlansoprazole Sustained Release Capsule Sale by Application (2021-2026) & (K Units)
Table 11. Global Dexlansoprazole Sustained Release Capsule Sale Market Share by Application (2021-2026)
Table 12. Global Dexlansoprazole Sustained Release Capsule Revenue by Application (2021-2026) & ($ million)
Table 13. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Application (2021-2026)
Table 14. Global Dexlansoprazole Sustained Release Capsule Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Dexlansoprazole Sustained Release Capsule Sales by Company (2021-2026) & (K Units)
Table 16. Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Company (2021-2026)
Table 17. Global Dexlansoprazole Sustained Release Capsule Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Company (2021-2026)
Table 19. Global Dexlansoprazole Sustained Release Capsule Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Dexlansoprazole Sustained Release Capsule Producing Area Distribution and Sales Area
Table 21. Players Dexlansoprazole Sustained Release Capsule Products Offered
Table 22. Dexlansoprazole Sustained Release Capsule Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Dexlansoprazole Sustained Release Capsule Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Dexlansoprazole Sustained Release Capsule Sales Market Share Geographic Region (2021-2026)
Table 27. Global Dexlansoprazole Sustained Release Capsule Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Dexlansoprazole Sustained Release Capsule Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Country/Region (2021-2026)
Table 31. Global Dexlansoprazole Sustained Release Capsule Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Dexlansoprazole Sustained Release Capsule Sales by Country (2021-2026) & (K Units)
Table 34. Americas Dexlansoprazole Sustained Release Capsule Sales Market Share by Country (2021-2026)
Table 35. Americas Dexlansoprazole Sustained Release Capsule Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Dexlansoprazole Sustained Release Capsule Sales by Type (2021-2026) & (K Units)
Table 37. Americas Dexlansoprazole Sustained Release Capsule Sales by Application (2021-2026) & (K Units)
Table 38. APAC Dexlansoprazole Sustained Release Capsule Sales by Region (2021-2026) & (K Units)
Table 39. APAC Dexlansoprazole Sustained Release Capsule Sales Market Share by Region (2021-2026)
Table 40. APAC Dexlansoprazole Sustained Release Capsule Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Dexlansoprazole Sustained Release Capsule Sales by Type (2021-2026) & (K Units)
Table 42. APAC Dexlansoprazole Sustained Release Capsule Sales by Application (2021-2026) & (K Units)
Table 43. Europe Dexlansoprazole Sustained Release Capsule Sales by Country (2021-2026) & (K Units)
Table 44. Europe Dexlansoprazole Sustained Release Capsule Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Dexlansoprazole Sustained Release Capsule Sales by Type (2021-2026) & (K Units)
Table 46. Europe Dexlansoprazole Sustained Release Capsule Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Dexlansoprazole Sustained Release Capsule Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Dexlansoprazole Sustained Release Capsule
Table 52. Key Market Challenges & Risks of Dexlansoprazole Sustained Release Capsule
Table 53. Key Industry Trends of Dexlansoprazole Sustained Release Capsule
Table 54. Dexlansoprazole Sustained Release Capsule Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Dexlansoprazole Sustained Release Capsule Distributors List
Table 57. Dexlansoprazole Sustained Release Capsule Customer List
Table 58. Global Dexlansoprazole Sustained Release Capsule Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Dexlansoprazole Sustained Release Capsule Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Dexlansoprazole Sustained Release Capsule Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Dexlansoprazole Sustained Release Capsule Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Dexlansoprazole Sustained Release Capsule Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Dexlansoprazole Sustained Release Capsule Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Dexlansoprazole Sustained Release Capsule Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Dexlansoprazole Sustained Release Capsule Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Dexlansoprazole Sustained Release Capsule Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Dexlansoprazole Sustained Release Capsule Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Dexlansoprazole Sustained Release Capsule Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Dexlansoprazole Sustained Release Capsule Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Dexlansoprazole Sustained Release Capsule Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. TAKEDA PHARM Basic Information, Dexlansoprazole Sustained Release Capsule Manufacturing Base, Sales Area and Its Competitors
Table 73. TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Product Portfolios and Specifications
Table 74. TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. TAKEDA PHARM Main Business
Table 76. TAKEDA PHARM Latest Developments
Table 77. PAR PHARM Basic Information, Dexlansoprazole Sustained Release Capsule Manufacturing Base, Sales Area and Its Competitors
Table 78. PAR PHARM Dexlansoprazole Sustained Release Capsule Product Portfolios and Specifications
Table 79. PAR PHARM Dexlansoprazole Sustained Release Capsule Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. PAR PHARM Main Business
Table 81. PAR PHARM Latest Developments
Table 82. TWI PHARM Basic Information, Dexlansoprazole Sustained Release Capsule Manufacturing Base, Sales Area and Its Competitors
Table 83. TWI PHARM Dexlansoprazole Sustained Release Capsule Product Portfolios and Specifications
Table 84. TWI PHARM Dexlansoprazole Sustained Release Capsule Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. TWI PHARM Main Business
Table 86. TWI PHARM Latest Developments
LIST OF FIGURES
Figure 1. Picture of Dexlansoprazole Sustained Release Capsule
Figure 2. Dexlansoprazole Sustained Release Capsule Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dexlansoprazole Sustained Release Capsule Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Dexlansoprazole Sustained Release Capsule Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Dexlansoprazole Sustained Release Capsule Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Dexlansoprazole Sustained Release Capsule Sales Market Share by Country/Region (2025)
Figure 10. Dexlansoprazole Sustained Release Capsule Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 30MG
Figure 12. Product Picture of 60MG
Figure 13. Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Type in 2026
Figure 14. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Type (2021-2026)
Figure 15. Dexlansoprazole Sustained Release Capsule Consumed in Hospital
Figure 16. Global Dexlansoprazole Sustained Release Capsule Market: Hospital (2021-2026) & (K Units)
Figure 17. Dexlansoprazole Sustained Release Capsule Consumed in Clinic
Figure 18. Global Dexlansoprazole Sustained Release Capsule Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Dexlansoprazole Sustained Release Capsule Sale Market Share by Application (2025)
Figure 20. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Application in 2026
Figure 21. Dexlansoprazole Sustained Release Capsule Sales by Company in 2026 (K Units)
Figure 22. Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Company in 2026
Figure 23. Dexlansoprazole Sustained Release Capsule Revenue by Company in 2026 ($ millions)
Figure 24. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Company in 2026
Figure 25. Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Dexlansoprazole Sustained Release Capsule Sales 2021-2026 (K Units)
Figure 28. Americas Dexlansoprazole Sustained Release Capsule Revenue 2021-2026 ($ millions)
Figure 29. APAC Dexlansoprazole Sustained Release Capsule Sales 2021-2026 (K Units)
Figure 30. APAC Dexlansoprazole Sustained Release Capsule Revenue 2021-2026 ($ millions)
Figure 31. Europe Dexlansoprazole Sustained Release Capsule Sales 2021-2026 (K Units)
Figure 32. Europe Dexlansoprazole Sustained Release Capsule Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Dexlansoprazole Sustained Release Capsule Revenue 2021-2026 ($ millions)
Figure 35. Americas Dexlansoprazole Sustained Release Capsule Sales Market Share by Country in 2026
Figure 36. Americas Dexlansoprazole Sustained Release Capsule Revenue Market Share by Country (2021-2026)
Figure 37. Americas Dexlansoprazole Sustained Release Capsule Sales Market Share by Type (2021-2026)
Figure 38. Americas Dexlansoprazole Sustained Release Capsule Sales Market Share by Application (2021-2026)
Figure 39. United States Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Dexlansoprazole Sustained Release Capsule Sales Market Share by Region in 2026
Figure 44. APAC Dexlansoprazole Sustained Release Capsule Revenue Market Share by Region (2021-2026)
Figure 45. APAC Dexlansoprazole Sustained Release Capsule Sales Market Share by Type (2021-2026)
Figure 46. APAC Dexlansoprazole Sustained Release Capsule Sales Market Share by Application (2021-2026)
Figure 47. China Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 51. India Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Dexlansoprazole Sustained Release Capsule Sales Market Share by Country in 2026
Figure 55. Europe Dexlansoprazole Sustained Release Capsule Revenue Market Share by Country (2021-2026)
Figure 56. Europe Dexlansoprazole Sustained Release Capsule Sales Market Share by Type (2021-2026)
Figure 57. Europe Dexlansoprazole Sustained Release Capsule Sales Market Share by Application (2021-2026)
Figure 58. Germany Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 59. France Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Market Share by Application (2021-2026)
Figure 66. Egypt Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Dexlansoprazole Sustained Release Capsule in 2026
Figure 72. Manufacturing Process Analysis of Dexlansoprazole Sustained Release Capsule
Figure 73. Industry Chain Structure of Dexlansoprazole Sustained Release Capsule
Figure 74. Channels of Distribution
Figure 75. Global Dexlansoprazole Sustained Release Capsule Sales Market Forecast by Region (2027-2032)
Figure 76. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Dexlansoprazole Sustained Release Capsule Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Dexlansoprazole Sustained Release Capsule Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Dexlansoprazole Sustained Release Capsule
Figure 2. Dexlansoprazole Sustained Release Capsule Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dexlansoprazole Sustained Release Capsule Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Dexlansoprazole Sustained Release Capsule Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Dexlansoprazole Sustained Release Capsule Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Dexlansoprazole Sustained Release Capsule Sales Market Share by Country/Region (2025)
Figure 10. Dexlansoprazole Sustained Release Capsule Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 30MG
Figure 12. Product Picture of 60MG
Figure 13. Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Type in 2026
Figure 14. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Type (2021-2026)
Figure 15. Dexlansoprazole Sustained Release Capsule Consumed in Hospital
Figure 16. Global Dexlansoprazole Sustained Release Capsule Market: Hospital (2021-2026) & (K Units)
Figure 17. Dexlansoprazole Sustained Release Capsule Consumed in Clinic
Figure 18. Global Dexlansoprazole Sustained Release Capsule Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Dexlansoprazole Sustained Release Capsule Sale Market Share by Application (2025)
Figure 20. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Application in 2026
Figure 21. Dexlansoprazole Sustained Release Capsule Sales by Company in 2026 (K Units)
Figure 22. Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Company in 2026
Figure 23. Dexlansoprazole Sustained Release Capsule Revenue by Company in 2026 ($ millions)
Figure 24. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Company in 2026
Figure 25. Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Dexlansoprazole Sustained Release Capsule Sales 2021-2026 (K Units)
Figure 28. Americas Dexlansoprazole Sustained Release Capsule Revenue 2021-2026 ($ millions)
Figure 29. APAC Dexlansoprazole Sustained Release Capsule Sales 2021-2026 (K Units)
Figure 30. APAC Dexlansoprazole Sustained Release Capsule Revenue 2021-2026 ($ millions)
Figure 31. Europe Dexlansoprazole Sustained Release Capsule Sales 2021-2026 (K Units)
Figure 32. Europe Dexlansoprazole Sustained Release Capsule Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Dexlansoprazole Sustained Release Capsule Revenue 2021-2026 ($ millions)
Figure 35. Americas Dexlansoprazole Sustained Release Capsule Sales Market Share by Country in 2026
Figure 36. Americas Dexlansoprazole Sustained Release Capsule Revenue Market Share by Country (2021-2026)
Figure 37. Americas Dexlansoprazole Sustained Release Capsule Sales Market Share by Type (2021-2026)
Figure 38. Americas Dexlansoprazole Sustained Release Capsule Sales Market Share by Application (2021-2026)
Figure 39. United States Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Dexlansoprazole Sustained Release Capsule Sales Market Share by Region in 2026
Figure 44. APAC Dexlansoprazole Sustained Release Capsule Revenue Market Share by Region (2021-2026)
Figure 45. APAC Dexlansoprazole Sustained Release Capsule Sales Market Share by Type (2021-2026)
Figure 46. APAC Dexlansoprazole Sustained Release Capsule Sales Market Share by Application (2021-2026)
Figure 47. China Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 51. India Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Dexlansoprazole Sustained Release Capsule Sales Market Share by Country in 2026
Figure 55. Europe Dexlansoprazole Sustained Release Capsule Revenue Market Share by Country (2021-2026)
Figure 56. Europe Dexlansoprazole Sustained Release Capsule Sales Market Share by Type (2021-2026)
Figure 57. Europe Dexlansoprazole Sustained Release Capsule Sales Market Share by Application (2021-2026)
Figure 58. Germany Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 59. France Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Market Share by Application (2021-2026)
Figure 66. Egypt Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Dexlansoprazole Sustained Release Capsule Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Dexlansoprazole Sustained Release Capsule in 2026
Figure 72. Manufacturing Process Analysis of Dexlansoprazole Sustained Release Capsule
Figure 73. Industry Chain Structure of Dexlansoprazole Sustained Release Capsule
Figure 74. Channels of Distribution
Figure 75. Global Dexlansoprazole Sustained Release Capsule Sales Market Forecast by Region (2027-2032)
Figure 76. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Dexlansoprazole Sustained Release Capsule Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Dexlansoprazole Sustained Release Capsule Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share Forecast by Application (2027-2032)
